Inhaled nucleic acid delivery systems for the treatment of pulmonary interstitial diseases: Challenges and opportunities

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Acta Pharmaceutica Sinica B

• Publication date

  2026-01-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.apsb.2025.12.047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Nebulized Lipid Nanoparticles Based on Degradable Ionizable Glycerolipid for Potent Pulmonary mRNA Delivery.

  2025cited by this paper
• Inhaled non-viral delivery systems for RNA therapeutics

  2025cited by this paper
• Spermine Significantly Increases the Transfection Efficiency of Cationic Polymeric Gene Vectors

  2025cited by this paper
• Histological signatures map anti-fibrotic factors in mouse and human lungs

  2025cited by this paper
• Formulation screening of lyophilized mRNA-lipid nanoparticles.

  2025cited by this paper
• Nucleic acid delivery by lipid nanoparticles for organ targeting

  2025cited by this paper
• Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis.

  2025cited by this paper
• Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying.

  2024cited by this paper
• Nebulized milk exosomes loaded with siTGF-β1 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability

  2024cited by this paper
• Senescence and tissue fibrosis: opportunities for therapeutic targeting.

  2024cited by this paper
• Immune mechanisms in fibrotic interstitial lung disease.

  2024cited by this paper
• Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases

  2024cited by this paper
• Near-infrared fluorescent probe with large Stokes shift and long emission wavelength for rapid diagnosis of lung cancer via aerosol inhalation delivery

  2024cited by this paper
• Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis.

  2024cited by this paper
• Advances and future perspectives of intranasal drug delivery: A scientometric review.

  2024cited by this paper
• In vivo editing of lung stem cells for durable gene correction in mice

  2024cited by this paper
• Effect of Nasal Inhalation on Drug Particle Deposition and Size Distribution in the Upper Airway: With Soft Mist Inhalers

  2024cited by this paper
• Zwitterionic Polymer-Functionalized Lipid Nanoparticles for the Nebulized Delivery of mRNA.

  2024cited by this paper
• Physiological and immunological barriers in the lung

  2024cited by this paper
• RNA Stability: A Review of the Role of Structural Features and Environmental Conditions

  2024cited by this paper
• Novel off-Targeting Events Identified after Genome Wide Analysis of CRISPR-Cas Edited Pigs

  2024cited by this paper
• 22nd AUTEX World Textile Conference

  2024cited by this paper
• Development of an Inhalable DNA Tetrahedron MicroRNA Sponge

  2024cited by this paper
• Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery

  2024cited by this paper
• Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy

  2024cited by this paper
• Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation.

  2024cited by this paper
• Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration.

  2024cited by this paper
• Pulmonary RNA Interference against Acute Lung Injury Mediated by Mucus- and Cell-penetrating Nanocomplexes.

  2024cited by this paper
• Advances in synthetic biology-based drug delivery systems for disease treatment

  2024cited by this paper
• ROS-responsive nanoparticles for bioimaging and treating acute lung injury by releasing dexamethasone and improving alveolar macrophage homeostasis

  2024cited by this paper
• Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA

  2024cited by this paper
• Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity

  2024cited by this paper
• The Role of Oxidative Stress in Tumorigenesis and Progression

  2024cited by this paper
• Targeting-specific Nanoprobes in the Second Near-infrared Window for Biomedical Applications

  2024cited by this paper
• A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein

  2024cited by this paper
• Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives

  2024cited by this paper
• Mucus-inspired lubricative antibacterial coating to reduce airway complications in an intubation cynomolgus monkey model

  2024cited by this paper
• Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination

  2024cited by this paper
• siRNA Nanoparticle Dry Powder Formulation with High Transfection Efficiency and Pulmonary Deposition for Acute Lung Injury Treatment.

  2024cited by this paper
• Tunable rigidity of PLGA shell-lipid core nanoparticles for enhanced pulmonary siRNA delivery in 2D and 3D lung cancer cell models.

  2024cited by this paper
• Nucleic acid drugs: recent progress and future perspectives

  2024cited by this paper
• An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids

  2024cited by this paper
• Evaluating β2-agonists as siRNA delivery adjuvants for pulmonary surfactant-coated nanogel inhalation therapy.

  2024cited by this paper
• An immunostimulatory liponanogel reveals immune activation-enhanced drug delivery and therapeutic efficacy in cancer.

  2024cited by this paper
• Impact of the diseased lung microenvironment on the in vivo fate of inhaled particles.

  2024cited by this paper
• Interstitial Lung Disease: A Review.

  2024cited by this paper
• Mitochondrial network dynamics in pulmonary disease: Bridging the gap between inflammation, oxidative stress, and bioenergetics

  2024cited by this paper
• Inhalation of taraxasterol loaded mixed micelles for the treatment of idiopathic pulmonary fibrosis

  2023cited by this paper
• Pulmonary Surfactant: A Mighty Thin Film.

  2023cited by this paper
• Advanced approaches to overcome biological barriers in respiratory and systemic routes of administration for enhanced nucleic acid delivery to the lung

  2023cited by this paper
• Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models

  2023cited by this paper
• ROS induced lipid peroxidation and their role in ferroptosis

  2023cited by this paper
• Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries

  2023cited by this paper
• Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA.

  2023cited by this paper
• Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA

  2023cited by this paper
• Understanding How Cationic Polymers’ Properties Inform Toxic or Immunogenic Responses via Parametric Analysis

  2023cited by this paper
• Sarcoidosis: Epidemiology and clinical insights

  2023cited by this paper
• RNA Nanomedicine: Delivery Strategies and Applications

  2023cited by this paper
• Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging

  2023cited by this paper
• Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery

  2023cited by this paper
• Inhalable pH-responsive DNA tetrahedron nanoplatform for boosting anti-tumor immune responses against metastatic lung cancer.

  2023cited by this paper
• Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection

  2023cited by this paper
• Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid‐Nanoparticle Components for Therapeutic and Vaccine Applications

  2023cited by this paper
• Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

  2023cited by this paper
• Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano-bio interactions.

  2023cited by this paper
• High-resolution bioenergetics correlates the length of continuous protonatable diaminoethane motif of four-armed oligo(ethanamino)amide transfectants to cytotoxicity.

  2023cited by this paper
• Inhalation delivery of nucleic acid gene therapies in preclinical drug development

  2023cited by this paper
• Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein Delivery

  2023cited by this paper
• Degrade the RNA

  2023cited by this paper
• Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid

  2023cited by this paper
• Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination

  2023cited by this paper
• A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications

  2023cited by this paper
• Inhaled multilevel size-tunable, charge-reversible and mucus-traversing composite microspheres as trojan horse: Enhancing lung deposition and tumor penetration

  2023cited by this paper
• Inhalable Bottlebrush Polymer Bioconjugates as Vectors for Efficient Pulmonary Delivery of Oligonucleotides

  2023cited by this paper
• Dual peptides-modified cationic liposomes for enhanced Lung cancer gene therapy by a gap junction regulating strategy

  2023cited by this paper
• Modular Design of Biodegradable Ionizable Lipids for Improved mRNA Delivery and Precise Cancer Metastasis Delineation In Vivo.

  2023cited by this paper
• Effective delivery of miR-511-3p with mannose-decorated exosomes with RNA nanoparticles confers protection against asthma.

  2023cited by this paper
• Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol.

  2023cited by this paper
• Factors affecting stability of RNA - temperature, length, concentration, pH, and buffering species.

  2023cited by this paper
• Inhalable Dry Powders of microRNA-laden Extracellular Vesicles Prepared by Thin-Film Freeze-Drying.

  2023cited by this paper
• PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA

  2023cited by this paper
• Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy

  2023cited by this paper
• Cystic Fibrosis: A Review.

  2023cited by this paper
• The role of macrophages polarization in sepsis-induced acute lung injury

  2023cited by this paper
• Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease

  2023cited by this paper
• Mucus Penetration of Surface-Engineered Nanoparticles in Various pH Microenvironments.

  2023cited by this paper
• The complementarity of DDR, nucleic acids and anti-tumour immunity

  2023cited by this paper
• Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021

  2023cited by this paper
• The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system

  2023cited by this paper
• The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo

  2023cited by this paper
• Pulmonary Delivery Nanomedicines Towards Circumventing Physiological Barriers: Strategies and Characterization Approaches.

  2022cited by this paper
• Exploring the intrinsic micro-/nanoparticle size on their in vivo fate after lung delivery.

  2022cited by this paper
• Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge

  2022cited by this paper
• Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?

  2022cited by this paper
• Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD

  2022cited by this paper
• The role of m6A RNA methylation in cancer metabolism

  2022cited by this paper
• Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Penetrating Peptides for the Lungs.

  2022cited by this paper
• Chemically Tuned Intracellular Gene Delivery by Core-Shell Nanoparticles: Effects of Proton Buffering, Acid Degradability, and Membrane Disruption

  2022cited by this paper
• Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation.

  2022cited by this paper
• Surface Coating of Pulmonary siRNA Delivery Vectors Enabling Mucus Penetration, Cell Targeting, and Intracellular Radical Scavenging for Enhanced Acute Lung Injury Therapy.

  2022cited by this paper

• No citing papers are available for this paper.